Contract with Customer, Liability, Noncurrent of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. from 30 Dec 2017 to 27 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 30 Dec 2017 to 27 Sep 2025.
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Contract with Customer, Liability, Noncurrent for the quarter ending 27 Sep 2025 was $42,492,000, a 22% increase year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $42,492,000 +$7,577,000 +22% 27 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $37,666,000 +$8,527,000 +29% 28 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $33,945,000 +$1,497,000 +4.6% 29 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $34,291,000 +$3,372,000 +11% 28 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $34,915,000 28 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $29,139,000 29 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $32,448,000 30 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $30,919,000 30 Dec 2023 10-Q 06 Nov 2024 2024 Q3
Q3 2022 $24,161,000 +$5,656,000 +31% 24 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $20,766,000 +$2,510,000 +14% 25 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $22,922,000 +$2,879,000 +14% 26 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $20,578,000 +$1,103,000 +5.7% 25 Dec 2021 10-Q 02 Nov 2022 2022 Q3
Q3 2021 $18,505,000 -$618,000 -3.2% 25 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $18,256,000 +$2,468,000 +16% 26 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $20,043,000 +$3,965,000 +25% 27 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $19,475,000 -$1,508,000 -7.2% 26 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $19,123,000 -$6,225,000 -25% 26 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $15,788,000 -$11,956,000 -43% 27 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $16,078,000 -$12,741,000 -44% 28 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $20,983,000 -$13,437,000 -39% 28 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 $25,348,000 -$12,223,000 -33% 28 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $27,744,000 29 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $28,819,000 30 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $34,420,000 +$26,107,000 +314% 29 Dec 2018 10-K 11 Feb 2020 2019 FY
Q3 2018 $37,571,000 29 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q4 2017 $8,313,000 30 Dec 2017 10-K 13 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.